Keynote Speakers
Clark Chen
Co-Director, University of California-San Diego | 
Dolores Di Vizio
Professor, Cedars Sinai Medical Center | 
Michael Heller
Professor, Dept Bioengineering, University of California-San Diego | 
Raghu Kalluri
Professor and Chairman, Department of Cancer Biology, University of Texas MD Anderson Cancer Center | 
Walter Koch
Vice President, Roche Molecular Systems | 
Fred Kramer
Professor of Microbiology, Biochemistry & Molecular Genetics, New Jersey Medical School Rutgers University | 
Minetta Liu
Associate Professor and Chair, Oncology Research, Mayo Clinic | 
Y. Peng Loh
Chief and Senior Investigator, Section on Cellular Neurobiology, Eunice Kennedy Shriver National Institute of Child health and Human Development, National Institutes of Health (NIH) | 
Chamindie Punyadeera
Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology | 
Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands | 
Lidong Qin
Professor and CPRIT Scholar, Houston Methodist Research Institute | 
Sehyun Shin
Professor & Director, Nano-Biofluignostic Engineering Research Center, Korea University and Anam/Guro Hospital of Korea University | 
John Sninsky
Chief Scientific Officer, CareDx | 
Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas | 
AmirAli Talasaz
Co-Founder, President & COO, Guardant Health | 
Hsian-Rong Tseng
Professor, Crump Institute for Molecular Imaging, California NanoSystems Institute, University of California-Los Angeles | 
Weian Zhao
Associate Professor, Department of Biomedical Engineering, University of California-Irvine |
OverviewThe 3rd Annual Liquid Biopsies and Minimally-Invasive Diagnostics 2016 Conference
brings together academic researchers, industry researchers, as well as
biotechnology and pharmaceutical companies to explore the expanding and
evolving field whereby Circulating Biomarkers of various classes are
being evaluated for their potential to be developed into diagnostics for
cancer as well as other disease classes.
|
|
This Liquid Biopsies Conference focuses primarily on
biofluid-based molecular biomarkers, such as circulating tumor DNA
(ctDNA) as well as circulating tumor cells (CTCs), and protein-based
circulating biomarkers. There is much interest in the potential of
ctDNA for developing biological fluid-based biopsies (such as using
plasma, urine, or other biofluids) and the presenters in this track
bring together the most up-to-date information and current
state-of-the-field. The conference further explores the potential of various minimally-invasive circulating
biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and
Extracellular Vesicles (EVs), for development of novel diagnostics for
patient monitoring and precision/targeted medicine. Authors of best abstracts would be offered with the opportunity to publish their full articles in “Special Issue on Liquid Biopsy” of Cancer Translational Medicine Journal.
Agenda Topics- Circulating Tumor Cells (CTCs): Potential for Development of Liquid Biopsies
- Circulating Tumor DNA (ctDNA): Potential for Development of Liquid Biopsies
- Extracellular Nucleic Acids in the Circulation: Circulating Free DNA, Extracellular RNA and Circulating microRNA/Long Non-Coding RNA
- Extracellular Vesicles (EVs): Potential for Development of Liquid Biopsies
- US vs. EU vs. Asia/Pacific Regulatory Landscape for Novel Minimally-Invasive Diagnostics
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865
|
Distinguished FacultyMuller Fabbri, Assistant Professor, University of Southern California
Shivani Sharma, Associate Director, California NanoSystems Institute, California NanoSystems Institute, UCLA
Louise Laurent, Associate Professor, University of California-San Diego
James Joyce, Chairman & CEO, Aethlon Medical, Inc.
Eric Kaldjian, Chief Medical Officer, RareCyte
Lyle Arnold, Chief Scientific Officer, Biocept
David Freedman, Co-Founder & CEO, nanoView Diagnostics Inc.
James Han, Director, Bioinformatics, Genomic Health
Kendall Van Keuren-Jensen, Professor and Deputy Director, Translational Genomics Research Institute
Ian Papautsky, Richard and Loan Hill Professor of Bioengineering, Co-Director, NSF Center for Advanced Design & Manufacturing of Integrated Microfluidics, University of Illinois at Chicago
Iwijn De Vlaminck, Robert N. Noyce Assistant Professor in Life Science and Technology Meinig School of Biomedical Engineering, Cornell University
Anders Nygren, Senior Director, Research and Development, Agena Biosciences
Lingzhi Wang, Senior Research Scientist, Ctr. for Translational Medicine, Adjunct Professor, National University of Singapore
Karl Hecker, Vice President of Product Development, Rubicon Genomics, Inc.
|
| Corporate Sponsors | Web Sponsors | Offical Journal Partner | Networking |
| |  |  |
|
Liquid Biopsy Slide Deck
